In collaboration with Chiesi Group And SYNLAB Italy, EIT Health – part of the European Institute of Innovation and Technology (EIT), a body of the European Union – launched the new programme InnoStars Connect.
This is an Open Innovation initiative that aims to bring together start-ups, SMEs, researchers, universities and hospitals in Italy and in emerging European countries and in ultra-peripheral regions, in order to create innovations capable of changing lives .
Through the program, the 10 selected organizations will be able to access the largest healthcare innovation network, funding and professional guidance, to experiment with innovative solutions capable of responding to healthcare challenges. The top three teams will compete during theEIT Health InnoStars Grand Final to win the final prize of 10,000 euros. The deadline for submitting applications is June 30, 2024.
Start-ups, SMEs, hospitals, universities and research institutes from across Europe (from the countries covered by the regulation) that have innovative solutions to address the identified challenges are invited to apply to the InnoStars Connect programme. Eligible applicants must have a solution with a maturity level between TRL 5 (technology validated in a relevant environment) e TRL 7 (demonstration of a system prototype in an operational environment) and be ready to collaborate in Open Innovation.
Individual organizations that are not currently EIT Health partners should become EIT Health InnoStars partners. By participating in the program, they will have access to a broad network and resources that offer transformative collaborations with leading healthcare innovators.
“We are looking for exemplary and talented innovators among start-ups, SMEs, hospitals, universities and research institutions in Italy and abroad who want to collaborate with us on Open Innovation opportunities – he declares Fabrizio Conicella, Head of Center of Open Innovation & Competence, Chiesi Group – Our goal is to go beyond current boundaries, study new approaches and develop better models. By combining our expertise with that of InnoStars Connect, we envision pioneering solutions that respond to the evolving needs of patients and healthcare systems. Together we can address the challenges generated by the interconnection between planetary health and human health, promoting a healthier future for all.”
“We see enormous potential for diagnostic biomarkers and innovative technologies to revolutionize healthcare delivery – he adds Maurizio Ferrari, CMO Chief Medical Officer SYNLAB Italy – Through InnoStars Connect, we are keen to collaborate with innovators across Europe to find creative solutions that improve our services and patient outcomes. By joining forces with us, innovators can help us find new ways to deliver cutting-edge diagnostics that will shape the future of healthcare for millions of European citizens.”
